A Risk Sciences International news item posted on December 12, 2016 and last updated on August 18, 2019

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult use of psychiatric drugs using publicly available, nationally representative data.  These analyses demonstrate that 1 of 6 US adults reported taking psychiatric drugs at least once during 2013, but with 2- to 3-fold differences by race/ethnicity, age, and sex.

http://www.nytimes.com/2016/12/12/health/one-in-6-american-adults-say-they-have-taken-psychiatric-drugs-report-says.html

http://www.cbsnews.com/news/psychiatric-drugs-study-reveals-widespread-use-women-men/

To read the journal article, click here.

 

 

 

 

More RSI News

RSI CEO Greg Paoli Named Fellow of the Society for Risk Analysis

January 12, 2026

Risk Sciences International (RSI) is proud to announce that CEO Greg Paoli has been designated as a Fellow of the Society for Risk Analysis (SRA).…

Bias Assessment in Case-Control and Cohort Studies for Hazard Identification

November 4, 2025

IARC recently published a volume on quantitative bias modelling: Bias assessment in case–control and cohort studies for hazard identification (IARC Scientific Publication No. 171). We…

RSI Helps Strengthen Food Safety Culture in Vietnam

October 21, 2025

In mid-October 2025, Vietnamese and Canadian experts convened in Đà Nẵng to exchange approaches for strengthening food safety through risk science. The workshop brought together…

Use of Probabilistic Exposure Models in the Assessment of Dietary Exposure to Chemicals 

August 26, 2025

Risk Sciences International CEO, Greg Paoli and RSI senior experts Emma Hartnett and Paul Price, have co-authored a new peer-reviewed publication highlighting the critical role…